JP2019526810A5 - - Google Patents

Download PDF

Info

Publication number
JP2019526810A5
JP2019526810A5 JP2019517154A JP2019517154A JP2019526810A5 JP 2019526810 A5 JP2019526810 A5 JP 2019526810A5 JP 2019517154 A JP2019517154 A JP 2019517154A JP 2019517154 A JP2019517154 A JP 2019517154A JP 2019526810 A5 JP2019526810 A5 JP 2019526810A5
Authority
JP
Japan
Prior art keywords
biomarkers
determining
amount
sle
test sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019517154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019526810A (ja
Filing date
Publication date
Priority claimed from GBGB1609951.7A external-priority patent/GB201609951D0/en
Application filed filed Critical
Publication of JP2019526810A publication Critical patent/JP2019526810A/ja
Publication of JP2019526810A5 publication Critical patent/JP2019526810A5/ja
Pending legal-status Critical Current

Links

JP2019517154A 2016-06-07 2017-06-07 バイオマーカーサインおよびそれらの使用 Pending JP2019526810A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1609951.7 2016-06-07
GBGB1609951.7A GB201609951D0 (en) 2016-06-07 2016-06-07 Biomarkers signatures and uses thereof
PCT/EP2017/063855 WO2017211896A1 (en) 2016-06-07 2017-06-07 Biomarker signatures of systemic lupus erythematosus and uses thereof

Publications (2)

Publication Number Publication Date
JP2019526810A JP2019526810A (ja) 2019-09-19
JP2019526810A5 true JP2019526810A5 (enExample) 2020-07-16

Family

ID=56508210

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019517154A Pending JP2019526810A (ja) 2016-06-07 2017-06-07 バイオマーカーサインおよびそれらの使用

Country Status (12)

Country Link
US (2) US20200041504A1 (enExample)
EP (1) EP3465209A1 (enExample)
JP (1) JP2019526810A (enExample)
KR (1) KR20190038791A (enExample)
CN (1) CN109690312A (enExample)
AU (1) AU2017277583A1 (enExample)
BR (1) BR112018075223A2 (enExample)
CA (1) CA3026574A1 (enExample)
GB (1) GB201609951D0 (enExample)
MX (1) MX2018015140A (enExample)
RU (1) RU2018142846A (enExample)
WO (1) WO2017211896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
WO2020081204A1 (en) * 2018-10-18 2020-04-23 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
GB201904472D0 (en) * 2019-03-29 2019-05-15 Immunovia Ab Methods, arrays and uses thereof
CN118948243B (zh) * 2024-07-23 2025-10-17 中国医科大学附属第一医院 基于机器学习对神经精神狼疮进行影像组学诊断的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039578B1 (en) 1980-05-02 1985-04-10 Edward P. Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US20070141627A1 (en) * 2005-10-19 2007-06-21 Behrens Timothy W Systemic Lupus Erythematosus
GB201014837D0 (en) * 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
WO2014008426A2 (en) * 2012-07-06 2014-01-09 Ignyta, Inc. Diagnosis of systemic lupus erythematosus
US20160223537A1 (en) * 2013-09-11 2016-08-04 Singapore Health Services Pte Ltd Identification of novel biomarkers of flares of systemic lupus erythematosus
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
GB201410226D0 (en) * 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same
CA2997838A1 (en) * 2014-10-07 2016-04-14 University Health Network Urinary biomarkers for sle and lupus nephritis

Similar Documents

Publication Publication Date Title
JP2019526810A5 (enExample)
Parker et al. Mass spectrometry based biomarker discovery, verification, and validation–quality assurance and control of protein biomarker assays
JP2014508298A5 (enExample)
EA202090247A1 (ru) Антитела против cd166 и их применения
EA201890383A1 (ru) Конструкции биспецифических антител, связывающиеся с мезотелином и кд3 (cd3)
MX2019000476A (es) Anticuerpos especificos para la tau hiperfosforilada y sus metodos de uso.
WO2016094761A3 (en) Test apparatus and methods for st2 cardiac biomarker
EA200701211A1 (ru) Полипептиды, которые связываются с br3, и их применение
JP2015527365A5 (enExample)
JP2016512214A5 (enExample)
JP2015531768A5 (enExample)
JP2012073260A5 (enExample)
JP2016528236A5 (enExample)
JP2016536568A5 (enExample)
JP2015502547A5 (enExample)
ATE474857T1 (de) Antikörper gegen ein epitop auf agr2, assays und hybridome
JP2018527895A5 (enExample)
Suo et al. Phage display for identifying peptides that bind the spike protein of transmissible gastroenteritis virus and possess diagnostic potential
JP2008503737A5 (enExample)
WO2005100995A3 (en) Methods of determining allergen response using microarray imminoassay techinques
JP2016535270A5 (enExample)
JP2015529211A5 (enExample)
JP2010526995A5 (enExample)
JP2017524933A5 (enExample)
RU2018142846A (ru) Характерные наборы биомаркеров системной красной волчанки и их применение